[CYCC] YoY Quarter Result on 30-Sep-2014 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
12-Nov-2014
Financial Year
2014
Quarter
30-Sep-2014 [#Q3]
Profit Trend
QoQ- -1.97%
YoY- 1.94%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Revenue 0 205 715 735 309 38 164 -
PBT -2,076 -3,400 -3,187 -5,661 -5,746 -3,572 -3,571 -8.63%
Tax -219 -454 -478 -750 -730 -419 -126 9.64%
NP -1,857 -2,946 -2,709 -4,907 -5,004 -1,890 -3,445 -9.77%
Tax Rate - - - - - - - -
Total Cost 1,857 3,151 3,424 5,642 5,313 1,928 3,609 -10.47%
Ratio Analysis
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
NP Margin 0.00 -1,437.07 -378.88 -667.62 -1,619.42 -4,973.68 -2,100.61 -
Per Share
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
EPS -3.78 -16.96 -18.75 -51.93 -67.51 -53.81 -107.75 -42.75%
EPS Diluted -3.78 -16.96 -18.75 -51.93 -67.51 -53.81 -107.75 -42.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.